In Fiji, 1 in 3 adults has diabetes. In Tonga and Samoa, it's even higher. Health systems across the Pacific are overwhelmed. GlucoToq brings AI-powered, affordable, continuous diabetes management to the communities that need it most.
Diabetes Control Informatics: diabetes information collected to support informed advice and care.
No region on Earth faces a more urgent diabetes burden than the Pacific. The numbers are not just alarming — they are a call to action.
Diabetes is no longer a disease of wealthy nations. It is a global emergency that strikes hardest where resources are scarcest.
252 million people have diabetes and don't know it. That's 42.8% of all cases globally. They walk into hospitals with advanced complications that could have been prevented.
Diabetes will cost the global economy $10.2 trillion between 2020 and 2050. Including informal caregiving, the burden explodes to $78.8 trillion — equivalent to 1.7% of global GDP.
3 in 4 adults with diabetes live in low- and middle-income countries. 90% of untreated cases are in these regions. Less than 5% of countries meet WHO diagnosis targets.
When diabetes is unmanaged, the bill comes due in emergency rooms, amputation wards, and dialysis centers.
Direct medical costs, lost productivity, and premature mortality across 204 countries.
Already 1.8% of global GDP. Projected to hit $2.5 trillion by 2030 even if targets are met.
Type 2 diabetes patients face dramatically elevated cardiovascular risk — the leading driver of hospitalization costs.
Almost 450 million adults receive no glucose-lowering medication. Complications are inevitable.
252 million adults walk around with untreated diabetes, developing irreversible complications.
Compared to 28.9% in high-income countries. Poverty and diabetes form a deadly feedback loop.
81.8% of all undiagnosed cases. Half of them live in just three nations: China, India, Indonesia.
An AI-powered platform that connects patients, devices, and health systems in one intelligent loop — designed for connectivity-challenged, resource-limited environments.
Real-time sync with Dexcom G7, FreeStyle Libre, and Apple Watch. Patients and providers see the same data, instantly. No more blind spots between clinic visits — critical when specialists are on another island.
GPT-4 pattern detection identifies trends humans miss — breakfast spikes, hydration correlations, nighttime lows. Actionable insights, not just raw numbers. Works offline and syncs when connectivity returns.
Glucose, food, water, insulin — all in one place. Barcode scanning for carbs. Smart reminders for medication. The friction of daily management disappears, even for patients with limited digital literacy.
Auto-generated weekly reports export directly to PDF. Endocrinologists get structured data, trend analysis, and AI recommendations — no more fragmented notebooks. Share via WhatsApp, email, or print.
GlucoToq dietitians monitor each patient's calorie intake alongside their glucose readings, so advice is based on real data rather than guesswork.
Meal plans are designed around locally grown and widely eaten foods: dalo, cassava, breadfruit, bananas and other tropical fruit, and fresh fish, with simple swaps and preparation tips that ease glucose spikes.
Part of our data collection is done by phone. Our team calls patients to record meals, glucose readings and symptoms, and automated voice check-ins reach people on basic phones. This information supports informed advice and care.
Real stories from the communities GlucoToq is built to serve.
Before GlucoToq, I was checking my sugar once a week and guessing my insulin. Now I see patterns I never noticed. My HbA1c dropped from 10.2 to 7.1 in three months. My doctor in Suva can see my data without me flying there.
We piloted GlucoToq across 12 rural health centres in Fiji. Patient engagement tripled. Emergency admissions for DKA dropped 40% in six months. This is the kind of digital health intervention that actually scales in the Pacific.
My 11-year-old son has Type 1. With GlucoToq Family, I can see his glucose at school in real time. The AI warned us about nighttime lows we were missing. It has given us something we never had before: peace of mind.
We evaluated six diabetes platforms for our Pacific Island health network. GlucoToq was the only one that worked reliably on 3G, integrated with both Dexcom and FreeStyle, and generated clinician-ready reports in under 30 seconds.
The weekly AI report told me my post-lunch spikes were linked to dehydration, not just carbs. I increased my water intake and my time-in-range jumped from 58% to 81%. The app pays for itself in avoided complications.
Available on iOS and Android. Start your free 7-day trial of Pro — no credit card required. Works offline, syncs when connected.
Start with Pro free for one week. No credit card. No commitment. Just better glucose control.
We built what others missed: AI intelligence, true CGM integration, and clinician-ready reports in one affordable platform.
| Feature | GlucoToq | mySugr | Glucose Buddy | Glooko | Happy Bob |
|---|---|---|---|---|---|
| Price (Premium) | $9.99/mo | $2.99/mo | $14.99/mo | Free | $9.99/mo |
| Free trial | 7 days Pro | Limited free | Ad-supported only | Free forever | 1 week |
| CGM Integration | Dexcom + Libre | Accu-Chek only | Dexcom G5/G6 | 100+ devices | Dexcom only |
| Smartwatch Sync | Apple Watch + Wear OS | Apple/Google Fit only | Fitbit + Apple | Limited | No |
| AI Pattern Detection | GPT-4 weekly reports | Basic analytics | Meal IQ only | None | Gamified only |
| Auto PDF Reports | One-click export | CSV + basic PDF | Premium PDF | Provider reports | No |
| Care Team Sharing | Built-in | No | No | Clinic-focused | Diabuddies |
| Family / Multi-profile | Up to 4 profiles | Single user | Single user | Single user | Limited |
| Water & Lifestyle Tracking | Built-in | No | No | No | No |
| Offline Mode | Full functionality | Limited | No | No | No |
| Clinic Dashboard | $49/mo B2B | No | No | Enterprise only | No |
Competitor pricing and features based on publicly available information as of 2026. Glooko is free for patients but enterprise-priced for clinics.
GlucoToq is not a consumer gadget. It is a population health infrastructure tool designed for Ministries of Health, hospital networks, and insurance providers across the Pacific and beyond.
Real-time visibility into thousands of patients. Identify high-risk cohorts before they hit the ER. Designed for island health networks with limited specialist coverage.
Early pattern detection prevents DKA, severe hypoglycemia, and foot ulcers — the most expensive complications. Our Fiji pilot saw a 40% drop in DKA admissions.
Community screening integration + remote monitoring brings undiagnosed patients into care pathways faster. Critical when 42% of Pacific diabetics don't know they have it.
Full offline functionality with smart sync when 3G/4G returns. Built for rural Pacific islands where connectivity is intermittent but diabetes is relentless.
End-to-end encryption. Compliance architecture for USA, EU, Australia, and Pacific health systems. Data sovereignty options for national health ministries.
Join health systems in Fiji, Australia, New Zealand, and the Pacific in deploying the next generation of diabetes management.